Community Group-Based Models of Medication Delivery: Applicability to Cardiovascular Diseases

Cordelia Kwon1, Ruth Webster2,3, Karla Santo2,4,5

  • 1College of Arts and Science, New York University, New York, US.

Global Heart
|May 27, 2021
PubMed

Insights

Chronic non-communicable diseases (NCDs) pose a global health challenge, especially in low-income countries. This study proposes adapting successful HIV/AIDS medication adherence models to improve NCD patient outcomes and access to care.

Area of Science:

  • Public Health
  • Health Services Research
  • Chronic Disease Management

Background:

  • Non-communicable diseases (NCDs) represent a growing global health burden, disproportionately affecting low- and middle-income countries.
  • Challenges in medication adherence, limited access to medicines, and weak community support exacerbate NCD mortality.
  • Existing healthcare systems face significant strain due to the rising prevalence of NCDs.

Purpose of the Study:

  • To propose a novel service delivery model for NCD management.
  • To leverage successful strategies from HIV/AIDS care for NCDs.
  • To address medication adherence and access barriers in NCD patients.

Main Methods:

  • Reviewing effective HIV/AIDS service delivery models, specifically community-based peer-support medication delivery groups.
  • Analyzing the applicability of models like medication adherence clubs and community antiretroviral therapy (ART) groups to NCDs.
  • Identifying similarities between NCD and HIV/AIDS patient needs and care pathways.

Main Results:

  • Community-based peer-support models have demonstrated success in improving medication adherence and patient satisfaction in HIV/AIDS care.
  • These models address key barriers such as access to medication and community support systems.
  • Potential for significant positive impact on NCD management, particularly for hypertension and cardiovascular disease.

Conclusions:

  • Models proven effective in HIV/AIDS care, such as adherence clubs, offer a viable framework for improving NCD management.
  • Adapting these community-centered approaches can enhance medication adherence and patient outcomes for chronic diseases.
  • This strategy holds promise for strengthening healthcare systems in resource-limited settings facing high NCD burdens.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
96
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.6K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
152
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
327
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
583
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
309